Ser215

Site Information
GtyQDVGsLNIGDVQ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 40268130

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	HER2 positive breast cancer ( 1 ) , luminal A breast cancer ( 1 ) , luminal B breast cancer ( 1 ) , breast cancer, triple negative ( 1 ) , lymphoma ( 2 ) , Burkitt's lymphoma ( 2 ) , follicular lymphoma ( 2 ) , mantle cell lymphoma ( 2 )
Relevant cell line - cell type - tissue:	BJAB (B lymphocyte) ( 2 ) , breast ( 1 ) , FL-318 (B lymphocyte) ( 2 ) , JEKO-1 (B lymphocyte) ( 2 ) , OCI-ly1 (B lymphocyte) ( 2 ) , RAMOS (B lymphocyte) ( 2 ) , SU-DHL-4 (B lymphocyte) ( 2 ) , UPN-1 (B lymphocyte) ( 2 )

References
1	Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62 27251275 Curated Info
2	Rolland D, et al. (2014) Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas. Am J Pathol 184, 1331-42 24667141 Curated Info